sorry, Tasman, yes, I meant “should”. Not “could”
They should be setting up a facility with SAMR credentials, capabilities and partnerships to push our reach further into China.
Between now and 2022 when DH said a2m takes 4 months to get product to china where it takes our competitors 2 weeks, and all the rumours since that a2m was exploring a china option - they could/should be closing in on a deal that pushes us in that direction with new SAMR/SKU etc
But Tasman certainly indicates its just a manufacturing facility for strategic upgrades, more control, better margins and supply security - the safe option, not a breakthrough move that china would offer.
I still support progress, and trust management and I believe they are closing in on finalising whatever it is they are working on. Whatever it is, let's keep moving forward. With all the potential to day dream about, but none of the facts and information, this is getting boring again.
- Forums
- ASX - By Stock
- A2M
- Media Updates
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

Media Updates, page-15379
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 7.710 |
4 | 5739 | 7.700 |
1 | 64 | 7.680 |
3 | 2750 | 7.670 |
1 | 500 | 7.660 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.990 | 8000 | 1 |
8.000 | 6318 | 7 |
8.010 | 6039 | 2 |
8.020 | 3294 | 2 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online